Somnos Clinical Research

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Chronic spontaneous urticaria2 trials
• Epilepsy2 trials
• Lung cancer2 trials
• ALS (motor neurone disease)1 trial
• Chronic kidney disease1 trial
• Chronic myeloid leukaemia1 trial
• IgA nephropathy1 trial
• Obstructive sleep apnoea1 trial
• Osteoporosis1 trial
• Postural tachycardia syndrome (POTS)1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials
• Phase 22 trials
• Phase 2/31 trial

Status

• Active, not recruiting6 trials
• Completed4 trials
• Recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Amgen2 trials
• Biohaven Therapeutics Ltd.2 trials
• Novartis Pharmaceuticals2 trials
• Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
• Bayer1 trial
• and 5 more

Running trials

• Recruiting

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· Phase 3· Prilenia· Source

• Recruiting

  Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

  NCT07143669· Blueprint Medicines Corporation· Source

  Contact: Blueprint Medicines

• Active, not recruiting

  A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

  NCT06868212· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· Phase 3· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Source

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06309966· Phase 2/3· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

  NCT05513001· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

  NCT05306288· Delfi Diagnostics Inc.· Source

• Active, not recruiting

  Screening for High Frequency Malignant Disease

  NCT05117840· Guardant Health, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Epilepsy1 recruiting
• Osteoporosis1 recruiting
• Postural tachycardia syndrome (POTS)1 recruiting

Closed trials

• Completed

  Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

  NCT06008678· Resvent Holding USA LTD· Source

• Completed

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· Phase 3· Amgen· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source

• Completed

  A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

  NCT05254002· Phase 2· Bayer· Source